SciELO - Scientific Electronic Library Online

 
vol.25 número1La epilepsia es una enfermedad compleja de circuitos con curaLocalización y morfología de las lesiones corticales en la esclerosis multiple índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Revista mexicana de neurociencia

versión On-line ISSN 2604-6180versión impresa ISSN 1665-5044

Rev. mex. neurocienc. vol.25 no.1 Ciudad de México ene./feb. 2024  Epub 16-Abr-2024

https://doi.org/10.24875/rmn.23000057 

ORIGINAL ARTICLES

Stroke-induced epilepsia partialis continua

Epilepsia partialis continua inducida por ictus

Amado Jiménez-Ruiz1 

Iván Roque-Sánchez2 

Juan C. Ayala-Alvarez2 

Omar Cárdenas-Saénz2 

Enrique Gómez-Figueroa2 

Victor Aguilar-Fuentes3 

José L. Ruiz-Sandoval1  * 

1Stroke and Cerebrovascular Disease Clinic, Department of Neurology, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara

2Department of Neurology, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara

3Faculty of Medicine, Benemérita Universidad Autónoma de Puebla, Puebla. Mexico


Abstract

Objective:

Focal status epilepticus requires timely diagnosis and treatment. Stroke is a common cause of epileptic seizures, but stroke-induced epilepsia partialis continua (SIEPC) is a rare type of focal status epilepticus with unknown management and prognosis. The aim of the study was to present a single-center case series of patients admitted to a third-level referral hospital diagnosed with SIEPC.

Methods:

We performed a retrospective review assessing all in-hospital consultations from July 2021 to July 2022 describing patients who presented with a diagnosis of SIEPC during hospital admission. Patients received standard diagnostic approaches (including electroencephalographic assessment) and treatment protocols. We defined EPC as focal, continuously repeated seizures with preserved consciousness lasting at least 1 h, confirmed with electroencephalography.

Results:

We identified 1054 patients seen by the neurology department as in-patient consultations. We found 268 patients with a diagnosis of stroke or epilepsy and then excluded 265 patients due to an alternate diagnosis. We finally identified three patients with (SIEPC).

Conclusions:

Although cerebrovascular disorders are a common cause of hospital admission, and SIEPC is rare, this condition is relevant to the practicing clinician. This study draws attention to this distinct clinical entity with variable presentation, diagnosis, treatment, and prognostic issues.

Keywords Stroke; Focal status epilepticus; Epilepsia partialis continua; Stroke-induced epilepsia partialis continua

Resumen

Objetivo:

El status epilepticus requiere un diagnóstico y tratamiento temprano. El ictus es una causa común de crisis epilépticas, pero la epilepsia partialis continua inducida por ictus es un tipo raro de status epilepticus focal con tratamiento y pronóstico desconocido. Presentar una serie de casos unicentrica de pacientes admitidos a un hospital de referencia de tercer nivel con diagnóstico de epilepsia partialis continua inducida por ictus.

Métodos:

Realizamos una revision retrospectiva, recopilando todas las interconsultas desde Julio del 2021 hasta Julio del 2022 que describieran pacientes quienes tuvieran un diagnóstico de epilepsia partialis continua inducida por ictus durante el ingreso hospitalario. Los pacientes recibieron abordajes diagnósticos (incluyendo realización de electroencefalograma) y terapéuticos estandar. Definimos epilepsia partialis continua como episodios convulsivos continuos focales con estado de consciencia preservado con duración mayor a una hora, confirmado por electroencefalografía.

Resultados:

Identificamos 1054 pacientes que fueron vistos por el servicio de neurología como interconsultas hospitalarias. A partir de dichos pacientes, encontramos 268 con diagnóstico de ictus o epilepsia, y excluimos 265 pacientes debido a diagnósticos alternativos. Finalmente, identificamos tres pacientes con epilepsia parcialis continua inducida por ictus.

Conclusiones:

A pesar de que las enfermedades cerebrovasculares son una causa frecuente de admisión hospitalaria, y la epilepsia parcialis continua inducida por infarto es rara, esta condición es relevante para el médico practicante. Este estudio llama la atención hacia esta distinta entidad clínica con presentación variable, y dificultades en el diagnóstico y tratamiento

Palabras clave Ictus; Status epilepticus focal; Epilepsia partialis continua; Epilepsia partialis continua inducida por ictus

Introduction

Epilepsia partialis continua (EPC) is part of the focal status epilepticus spectrum. Standardized management for this condition remains unknown. Stroke-induced EPC (SIEPC) is a rare disorder with unknown frequency. We aim to describe a single-center case series regarding this uncommon condition, emphasizing clinical outcomes.

Methods

We considered consecutive adult patients (≥ 18 years) with a history of stroke or epilepsy admitted to the Hospital Civil Fray Antonio Alcalde (Guadalajara, Mexico) from July 1, 2021, to July 1, 2022. Inclusion criteria were: ≥ 18 years, with an admission diagnosis of previous or acute stroke, history of post-stroke epilepsy, and SIEPC. Exclusion criteria were generalized status epilepticus and epilepsy before stroke. We identified 1052 patients seen in-hospital consultation using the electronic health record. During this period, 268 patients presented with the diagnosis of stroke or epilepsy. We identified eight patients with post-stroke epilepsy and excluded five due to generalized epilepsy diagnosis. We finally included three patients with a diagnosis of SIEPC (Fig. 1).

Figure 1 Flowchart. 

Patients received standard diagnostic (including electroencephalographic assessment) and treatment protocols. A board-certified neurologist made the diagnosis on clinical grounds and supported by brain imaging and electroencephalogram (EEG). We defined EPC as continuously repeated motor seizures with preserved consciousness lasting at least 1 h, confirmed with an electroencephalogram. We analyzed the following sociodemographic variables: age, gender, stroke risk factors (dyslipidemia, hypertension, diabetes, and atrial fibrillation), clinical symptoms, EEG findings, radiological findings in computerized tomography (CT) or magnetic resonance imaging (MRI), stroke localization, pharmacological treatment, the use of mechanical ventilation, clinical outcome, and follow-up.

Results

After a systematic search, we identified eight patients with post-stroke epilepsy. Three of these presented with SIEPC (< 1% frequency [0.28%]) (Table 1). All three patients had clinical, radiological, and electrophysiological findings consistent with SIEPC.

Table 1 Demographic and clinical information of patients with stroke-induced epilepsia partialis continua 

Case Sex Age Medical history Clinical presentation Imaging Radiologic diagnosis Abnormal EEG Treatment Pharmaco resistant epilepsy Death
1 F 49 Type 2 diabetes and hypothyroidism Hemifacial seizures with accompanying aphasia MRI IS + Levetiracetam (2 g every 12 h), Valproate (600 mg every 8 h), Carbamazepine (200 mg every 6 h), Lacosamide (200 mg every 12 h) + -
2 F 49 Hypertension, obesity, dyslipidemia Lingual seizures with accompanying motor faciobrachial progression MRI ICH + Levetiracetam (1 g every 12 h), Oxcarbazepine (600 mg every 12 h) - -
3 M 72 Type 2 diabetes, hypertension, and chronic kidney disease Hemiparesis with accompanying rhythmic clonic movements (synchronic, face-arm-leg) CT IS + Levetiracetam (1 g every 12 h), Phenytoin (100 mg every 8 h), Clonazepam (0.25 mg every 8 h), Valproate (1 g every 8 h) + -

MRI: magnetic resonance imaging; CT: computed tomography; EEG: electroencephalogram; IS: ischemic stroke; ICH: intracerebral hemorrhage.

Patient 1

A 49-year-old right-handed female experienced right hemifacial weakness. After 26 days of this event, she presented to the emergency room with repeated right hemifacial seizures, aphasia, and preserved awareness. Her medical history was relevant for Type 2 diabetes mellitus and hypothyroidism. Unenhanced brain computed tomography (CT) was unremarkable. MRI showed subacute infarction involving the left frontocortical and superior frontal gyrus (Fig. 2). The ictal standard scalp EEG reported the presence of continuous focal epileptiform discharges in the left centroparietal region and no secondary generalization. We treated her with levetiracetam, valproate, lacosamide, and carbamazepine (doses shown in Table 1). On 8-month follow-up, she remained seizure-free with levetiracetam and valproate. After extended workup, the stroke was classified as an embolic stroke of unknown source.

Figure 2 Diffusion-weighted image (A) shows diffusion restriction in the left superior frontal gyrus. Fluid-attenuated inversion recovery magnetic resonance imaging (B) confirms subacute infarction involving the left superior frontal gyrus. 

Patient 2

A 49-year-old right-handed female presented to the emergency room after experiencing lingual motor seizures with motor left faciobrachial progression. She had a history of hypertension, obesity, and dyslipidemia. CT scan revealed an intracerebral hemorrhage (ICH) in the right frontal lobe at the level of the precentral gyrus. Brain MRI showed a lesion at the same level (T2 hypointensity with isointense center and a "popcorn" appearance with associated perilesional edema) consistent with a cerebral cavernous venous malformation (cavernoma) (Fig. 3). The ictal standard scalp EEG showed right frontocentral discharges (F4-C4) with propagation to the contralateral hemisphere. At admission, we treated her with oxcarbazepine and levetiracetam (doses shown in Table 1). The patient responded well to pharmacotherapy.

Figure 3 Fluid-attenuated inversion recovery magnetic resonance imaging (MRI) (A) shows a hypointense lesion with an isointense center (popcorn appearance) and perilesional edema in the right parietal operculum. Susceptibility-weighted angiography MRI (B) reveals a hypointense lesion in the right parietal operculum. 

The lesion was surgically removed, and the patient remained seizure-free on 2-month follow-up.

Patient 3

A 72-year-old right-handed male presented to the emergency department with left hemiparesis and rhythmic, ipsilateral, and clonic movements (synchronic, face-arm-leg). He had a history of type 2 diabetes, hypertension, and chronic kidney disease. A brain CT scan showed a right temporal-occipital gyrus infarction consistent with a posterior cerebral artery territory stroke (Fig. 4). The ictal standard scalp EEG showed irregular rhythm, right hemispheric slowing, and lateralized periodic discharges (LPDs). The abnormal left-sided movements stopped abruptly after a benzodiazepine challenge but reinitiated acutely after a few minutes. The patient remained awake throughout the hospital admission and was treated with a combination of levetiracetam, phenytoin, clonazepam, and valproic acid with marked improvement (doses shown in Table 1). The patient was discharged against medical advice and was lost to follow-up. This patient's stroke was classified as cryptogenic due to an incomplete workup.

Figure 4 Brain computed tomography shows a hypointense lesion in the right temporo-occipital gyrus. 

Discussion

EPC was first described by Yakovlevich Kozhevnikov in 1894 but lacks a universally accepted definition1. It is a subtype of focal status epilepticus defined as continuous regular or irregular muscular clonic twitching affecting a limited body part for at least an hour2. Consciousness is typically preserved, and the twitching most commonly involves the face, arms, or both3. The diagnosis is usually supported with an EEG; however, it may be normal4. EPC is uncommon, but when identified, a common underlying cause is stroke4-6.

Stroke is the most common cause of epilepsy in older adults, accounting for approximately 20% of the cases7,8. The incidence of post-stroke status epilepticus is 0.1-0.9%9. Stroke is also the most common cause of status epilepticus in people over 60 years10. The risk of seizures is highest in the first week after stroke11. Early seizures (< 14 days after stroke) have a 35% increased risk of later epilepsy, but the risk of epilepsy after late seizures (> 14 days after stroke) increases to 90%12. The stroke subtype is also a significant predictor of seizures and epilepsy. Hemorrhagic stroke patients have a higher incidence of seizures compared to ischemic stroke. A symptomatic post-stroke seizure has a > 60% probability of seizure recurrence13. Large infarcts with cortical involvement increase the risk of epilepsy, and the localization of the lesion determines seizure type14.

SIEPC is rare, the frequency of this condition is unknown, and few studies have focused on determining its incidence. A prospective study conducted by Bentes et al. showed an incidence of 1.7% among 151 patients with stroke. However, the study sample was small, with no similar studies15.

The differential diagnosis for this rare condition includes cluster seizures (> 3 seizures in 24 h) and other abnormal movement disorders such as hemiballismus and hemichorea16. A benzodiazepine challenge (clonic movement cessation after IV administration of short-acting benzodiazepine) may help distinguish these entities.

Management of EPC remains to be seen. Studies are highly heterogeneous, with variable clinical responses to antiseizure drugs15. However, anti-seizure medications (ASMs) such as levetiracetam, carbamazepine, and lacosamide have shown promising responses with seizure resolution. These results, although showing adequate responses, should be taken with caution, since only one patient was included for each study17-19. Other approaches such as vagus nerve stimulation, transcranial brain stimulation, and alcohol; performed in four, one, and one patient, respectively; have also been used in EPC unresponsive to medical therapy20-22.

SIEPC response to ASMs is varied and presents a worse clinical response than EPC due to other etiologies. In a study conducted by Phabphal et al., all patients with EPC due to metabolic etiologies responded well to ASMs, but only 81% of the patients with SIEPC responded well to ASMs3. In our case series, all patients required two or more ASMs to archive clinical response. Levetiracetam was administered to all patients, with favorable outcomes; only one patient (Case 3) could not be evaluated in the follow-up but showed partial resolution within hospitalization. Previous studies have shown adequate clinical responses with the use of levetiracetam in SIEPC secondary to traumatic hemorrhagic intracerebral hemorrhage23, venous sinus thrombosis24, and ischemic stroke25,26. One of the limitations of these studies is that all were one patient-case reports; therefore, further studies should be conducted to confirm these findings. Other therapies used for SIEPC include fosphenytoin and clobazam27. The dose of ASMs could also impact the patient's outcome; in our series, we used either a dose of 1 g of levetiracetam every 12 h or 2 g every 12 h, similar to the doses used by Brigo et al26. and Haase et al23. Unfortunately, other case reports of SIEPC do not specify dosing.

In our case series, SIEPC secondary to ischemic stroke required more than two ASMs to archive clinical response, contrary, SIEPC secondary to ICH only required two ASMs to archive seizure resolution. Previously, Haase et al. showed similar results of seizure resolution of SIEPC secondary to ICH with the use of levetiracetam23.

Timing between seizure onset and treatment administration could also impact the clinical response of the patients since previous studies have shown that delayed treatment is related to longer duration of the episodes28. This could be explained by the greater momentum gained with the longer duration of the episodes6. Hyperglycemia may also contribute to worse clinical outcomes28,29. However, more studies should be conducted to confirm this hypothesis.

Our study has strengths and limitations. We acknowledge that it was a single-center retrospective design, and the small sample size may be a substantial limitation of our study. As an in-hospital consultation department, most patients are admitted to the geriatric or internal medicine ward. Patients with subtle clinical manifestations in other departments may be unrecognized.

Stroke is a prevalent neurological disorder in in-hospital admissions, and this complication must be correctly identified. Our study includes many screened patients with epilepsy or stroke. All patients were treated directly by us, and we were directly involved in the diagnosis and treatment. In this study, the frequency of SIEPC was low. However, cerebrovascular disease is a common cause of hospital admission, making this disorder clinically relevant. The lack of diagnostic criteria and treatment protocols for SIEPC is striking.

Conclusion

Stroke-induced epilepsia partialis continua is rare. However, given the high prevalence of stroke as a common cause for hospital admissions, it is essential for practicing physicians to be aware of this condition. This study draws attention to this distinct clinical entity with variable presentation, diagnosis, treatment, and prognostic issues. We need a precise diagnostic strategy for this patient population, and more studies are required to guide adequate management.

References

1. Vein AA, van Emde Boas W. Kozhevnikov epilepsy:the disease and its eponym. Epilepsia. 2011;52:212-8. [ Links ]

2. Mameniskiene R, Bast T, Bentes C, Canevini MP, Dimova P, Granata T, et al. Clinical course and variability of non-rasmussen, nonstroke motor and sensory epilepsia partialis continua:a European survey and analysis of 65 cases. Epilepsia. 2011;52:1168-76. [ Links ]

3. Phabphal K, Limapichat K, Sathirapanya P, Setthawatcharawanich S, Geater A. Clinical characteristics, etiology and long-term outcome of epilepsia partialis continua in adult patients in Thailand. Epilepsy Res. 2012;100:179-87. [ Links ]

4. MameniškienėR, Wolf P. Epilepsia partialis continua:a review. Seizure. 2017;44:74-80. [ Links ]

5. Bejr-Kasem H, Sala-PadróJ, Toledo M, Santamarina E, Sarria S, Gonzalez-Cuevas M, et al. Epilepsia partialis continua:aetiology, semiology and prognosis in a Spanish adult cohort. Epileptic Disord. 2016;18:391-8. [ Links ]

6. Thomas JE, Reagan TJ, Klass DW. Epilepsia partialis continua. A review of 32 cases. Arch Neurol. 1977;34:266-75. [ Links ]

7. Forsgren L, Beghi E, Oun A, SillanpääM. The epidemiology of epilepsy in Europe-a systematic review. Eur J Neurol. 2005;12:245-53. [ Links ]

8. Thijs RD, Surges R, O'Brien TJ, Sander JW. Epilepsy in adults. Lancet. 2019;393:689-701. [ Links ]

9. Rumbach L, Sablot D, Berger E, Tatu L, Vuillier F, Moulin T. Status epilepticus in stroke:report on a hospital-based stroke cohort. Neurology. 2000;54:350-4. [ Links ]

10. Waterhouse EJ, Vaughan JK, Barnes TY, Boggs JG, Towne AR, Kopec-Garnett L, et al. Synergistic effect of status epilepticus and ischemic brain injury on mortality. Epilepsy Res. 1998;29:175-83. [ Links ]

11. Ascoli M, Ferlazzo E, Gasparini S, Mastroianni G, Citraro R, Roberti R, et al. Epidemiology and outcomes of status epilepticus. Int J Gen Med. 2021;14:2965-73. [ Links ]

12. Sung CY, Chu NS. Epileptic seizures in thrombotic stroke. J Neurol. 1990;237:166-70. [ Links ]

13. Galovic M, Ferreira-Atuesta C, Abraira L, Döhler N, Sinka L, Brigo F, et al. Seizures and epilepsy after stroke:epidemiology, biomarkers and management. Drugs Aging. 2021;38:285-99. [ Links ]

14. Kammersgaard LP, Olsen TS. Poststroke epilepsy in the Copenhagen stroke study:incidence and predictors. J Stroke Cerebrovasc Dis. 2005;14:210-4. [ Links ]

15. Bentes C, Franco AC, Peralta AR, Viana P, Martins H, Morgado C, et al. Epilepsia partialis continua after an anterior circulation ischaemic stroke. Eur J Neurol. 2017;24:929-34. [ Links ]

16. Jafarpour S, Hirsch LJ, Gaínza-Lein M, Kellinghaus C, Detyniecki K. Seizure cluster:definition, prevalence, consequences, and management. Seizure. 2019;68:9-15. [ Links ]

17. Eggers C, Burghaus L, Fink GR, Dohmen C. Epilepsia partialis continua responsive to intravenous levetiracetam. Seizure. 2009;18:716-8. [ Links ]

18. Espay AJ, Schmithorst VJ, Szaflarski JP. Chronic isolated hemifacial spasm as a manifestation of epilepsia partialis continua. Epilepsy Behav. 2008;12:332-6. [ Links ]

19. Spalletti M, Comanducci A, Vagaggini A, Bucciardini L, Grippo A, Amantini A. Efficacy of lacosamide on seizures and myoclonus in a patient with epilepsia partialis continua. Epileptic Disord. 2013;15:193-6. [ Links ]

20. De Benedictis A, Freri E, Rizzi M, Franzini A, Ragona F, Specchio N, et al. Vagus nerve stimulation for drug-resistant epilepsia partialis continua:report of four cases. Epilepsy Res. 2013;107:163-71. [ Links ]

21. Misawa S, Kuwabara S, Shibuya K, Mamada K, Hattori T. Low-frequency transcranial magnetic stimulation for epilepsia partialis continua due to cortical dysplasia. J Neurol Sci. 2005;234:37-9. [ Links ]

22. Steve TA, Gross DW. Alcohol-responsive epilepsia partialis continua. Epileptic Disord. 2014;16:107-11. [ Links ]

23. Haase CG, Hopmann B. Epilepsia partialis continua successfully treated with levetiracetam. J Neurol. 2009;256:1020-1. [ Links ]

24. Chee YC, Yap TC. Epilepsia partialis continua (EPC) as an uncommon initial presentation of cerebral venous sinus thrombosis (CVST). Cureus. 2022;14:e22394. [ Links ]

25. Soler-Rico M, Denays R, Sinzobahamvya E. Abdominal epilepsia partialis continua due to cortical ischemia:a video-documented case report and review. Acta Neurol Belg. 2021;121:279-81. [ Links ]

26. Brigo F, Bratti A, Tavernelli V, Nardone R. Epilepsia partialis continua of the abdominal musculature caused by acute ischemic stroke. Can J Neurol Sci. 2018;45:703-6. [ Links ]

27. Shrivastava V, Burji NP, Basumatary LJ, Das M, Goswami M, Kayal AK. Etiological profile of epilepsia partialis continua among adults in a tertiary care hospital. Neurol India. 2013;61:156-60. [ Links ]

28. Gutiérrez-Viedma Ÿ, Romeral-Jiménez M, Serrano-García I, Parejo-Carbonell B, Cuadrado-Pérez ML, Sanz-Graciani I, et al. The importance of timing in epilepsia partialis continua. Neurología (Engl Ed). 2022;37:263-70. [ Links ]

29. Ku BD, An SJ, Yoon SS, Shin HY. Spontaneous interhemispheric subdural hematoma presenting as epilepsia partialis continua. Acta Neurol Belg. 2020;120:1457-60. [ Links ]

FundingThe authors declare that this work was carried out with the authors' own resources.

Ethical disclosures

Protection of human and animal subjects. The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data. The authors declare that no patient data appear in this article.

Right to privacy and informed consent. The authors declare that no patient data appear in this article.

Use of artificial intelligence for generating text. The authors declare that they have not used any type of generative artificial intelligence for the writing of this manuscript nor for the creation of images, graphics, tables, or their corresponding captions.

Received: September 04, 2023; Accepted: December 14, 2023

* Correspondence: José L. Ruiz-Sandoval E-mail: jorulej-1nj@prodigy.net.mx

Conflicts of interest

The authors declare that they have no conflicts of interest.

Creative Commons License Instituto Nacional de Cardiología Ignacio Chávez. Published by Permanyer. This is an open ccess article under the CC BY-NC-ND license